8-KRegulation FDExhibits & Filings

TransDigm Group INC 8-K Report, Regulation FD Disclosure (Apr 2, 2020)

Filed April 2, 2020For Securities:TDG

Summary

TransDigm Group Inc. (TDG) filed an 8-K on April 2, 2020, primarily to disclose information regarding a proposed offering of senior secured notes. The company also provided an update on the impact of the COVID-19 pandemic. Financially, the company highlighted its performance for the twelve-month period ended December 28, 2019, reporting net sales of $5,695 million and EBITDA As Defined of $2,613 million. Pro forma figures, which include the Esterline acquisition as if it occurred at the beginning of the period, showed an additional $286 million in net sales and $23 million in EBITDA As Defined. The company acknowledged the significant and evolving impact of the COVID-19 pandemic, particularly on its commercial aftermarket and OEM sales. In response, TransDigm plans to reduce its workforce by up to 15% and implement temporary furloughs. While designated an essential business, allowing operations to continue, the duration and severity of the pandemic's impact remain uncertain, with expectations of adverse effects on third-quarter results. The company is also reviewing potential benefits from the CARES Act.

Key Highlights

  • 1Proposed offering of senior secured notes by TransDigm Inc. to raise capital for general corporate purposes, including liquidity enhancement.
  • 2For the twelve months ended December 28, 2019, reported net sales of $5,695 million and EBITDA As Defined of $2,613 million.
  • 3Pro forma figures indicate the Esterline acquisition would have added approximately $286 million in net sales and $23 million in EBITDA As Defined for the twelve months ended December 28, 2019.
  • 4Acknowledged the significant and uncertain adverse impact of the COVID-19 pandemic on commercial aftermarket and OEM sales.
  • 5Announced workforce reduction of up to 15% and temporary furloughs due to the pandemic's expected impact on shipping levels.
  • 6Designated an essential business, allowing continued operations despite broader industry disruptions.
  • 7Currently examining the potential benefits of the CARES Act.
  • 8Anticipates a significant adverse impact on third-quarter fiscal 2020 sales, EBITDA As Defined, and net income.

Frequently Asked Questions

TransDigm Group is proposing to offer senior secured notes to raise capital for general corporate purposes, including increasing its liquidity.

The COVID-19 pandemic is expected to adversely impact TransDigm's commercial aftermarket and OEM sales in the near to long term. The company has designated as an essential business, allowing it to continue operations, but is implementing workforce reductions and furloughs in response to anticipated decreased shipping levels.

For the twelve-month period ended December 28, 2019, TransDigm reported net sales of $5,695 million and EBITDA As Defined of $2,613 million. The company also provided pro forma figures reflecting the Esterline acquisition, which would have added approximately $286 million in net sales and $23 million in EBITDA As Defined for the same period.

The company expects a significant adverse impact on its sales, EBITDA As Defined, and net income for the third quarter of fiscal 2020 due to the ongoing COVID-19 pandemic. The full impact remains difficult to predict due to the evolving nature of the pandemic.